Diaceutics 

$2.31
11
+$0.00+0%Wednesday 17:40

Statistics

Day High
2
Day Low
2
52W High
2.51
52W Low
1.3672
Volume
3,500
Avg. Volume
0
Mkt Cap
195.98M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Sep 22Expected
Q2 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
Q2 2026
-3.65
-0.93
1.78
4.5
Expected EPS
-2.781452785229366
Actual EPS
-3.248538177948954

Financials

0.12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
52.1MRevenue
62,433.42Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DIUXF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Diaceutics PLC, established in 2005 and headquartered in Belfast, UK, is a company dedicated to accelerating the commercialization of diagnostic solutions. It offers global pharmaceutical companies comprehensive data, advanced analytics, and implementation support. Central to its operations is the DXRX platform. This platform features DXRX data solutions, providing access to extensive diagnostic testing data pipelines from a broad network of laboratories, including real-time DXRX signal alerts, lab and physician mapping, and a testing dashboard. The DXRX platform also hosts a marketplace where laboratories, pharmaceutical firms, and diagnostic companies can connect to collaborate on precision medicine diagnostics. Diaceutics further provides DXRX Patient Journey, a tool for pharmaceutical clients to conduct detailed longitudinal analyses of individual patient biomarker testing paths, helping identify opportunities for earlier intervention and treatment. DXRX Lab Benchmarking allows laboratories to sharpen their competitive edge by comparing their key criteria against industry counterparts, encompassing metrics such as disease focus, testing methodologies, market share, turnaround times, and their standing as leaders in specific diagnostic fields. The DXRX Test Reimbursement service assists pharma clients in funding novel companion diagnostics, thereby shortening the time required for their widespread adoption. Furthermore, DXRX Test Signal delivers immediate notifications of testing events, empowering pharmaceutical clients to swiftly identify therapeutically actionable patients. Beyond the platform, Diaceutics furnishes services for diagnostic landscape analysis, strategic planning, implementation, and ongoing tracking, alongside expert consulting tailored to precision medicine diagnostics. Its extensive service portfolio also covers test standardization, quality evaluations, optimization of test reports, technical laboratory support, assistance with test access and reimbursement, laboratory training, and various educational resources.
Show More
CEO
Ryan Keeling
Employees
205
Country
Ireland
ISIN
GB00BJQTGV64
WKN
000A2PF80

Listings

0 Comments

Share your thoughts

FAQs

What is Diaceutics stock price today?▼
The current price of DIUXF is $2.31 USD — it has increased by +0% in the past 24 hours. Watch Diaceutics stock price performance more closely on the chart.
What is Diaceutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Diaceutics stocks are traded under the ticker DIUXF.
Is Diaceutics stock price growing?▼
DIUXF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Diaceutics has showed a +68.67% increase.
What is Diaceutics market cap?▼
Today Diaceutics has the market capitalization of 195.98M
When is the next Diaceutics earnings date?▼
Diaceutics is going to release the next earnings report on March 15, 2027.
What were Diaceutics earnings last quarter?▼
DIUXF earnings for the last quarter are -0.04 USD per share, whereas the estimation was -0.04 USD resulting in a -16.79% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Diaceutics revenue for the last year?▼
Diaceutics revenue for the last year amounts to 52.1M USD.
What is Diaceutics net income for the last year?▼
DIUXF net income for the last year is 62,433.42 USD.
How many employees does Diaceutics have?▼
As of November 22, 2026, the company has 205 employees.
In which sector is Diaceutics located?▼
Diaceutics operates in the Health & Wellness sector.
When did Diaceutics complete a stock split?▼
Diaceutics has not had any recent stock splits.
Where is Diaceutics headquartered?▼
Diaceutics is headquartered in Belfast, Ireland.